RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Severin Schwan

A collection of news and information related to Severin Schwan published by this site and its partners.

Top Severin Schwan Articles see all

Displaying items 1-5
  • Failed cancer vaccines might live again with new immune drugs

    MADRID (Reuters) - Using vaccines to fight cancer is a field littered with failures but experts believe it is possible the approach could get a new lease of life if such shots are combined with a new class of drugs called checkpoint inhibitors.
  • China hands drugmaker GSK record $489 million fine for paying bribes

    SHANGHAI/LONDON (Reuters) - China fined GlaxoSmithKline Plc a record 3 billion yuan ($489 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the...

    For Roche CEO, celebrating failure is key to success

    LONDON (Reuters) - Roche Chief Executive Severin Schwan likes to crack open the champagne with his drug research teams at the end of a big project - especially when they fail. As the boss of one of the world's most successful pharmaceutical companies,...

    Roche's $8 billion InterMune buy not a signal for more big deals

    LONDON (Reuters) - Roche's decision to buy U.S. biotech company InterMune for $8.3 billion last month was "exceptional" and not a sign of more ambitious plans for major acquisitions, the Swiss drugmaker' s chief executive said on Tuesday. Damping down...

    Roche to buy U.S. biotech firm InterMune for $8.3 billion

    Roche to buy U.S. biotech firm InterMune for $8.3 billion
    Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc. for $8.3 billion in cash, helping the world's leading maker of cancer drugs expand into the treatment of rare or incurable diseases. Roche's efforts to produce successful non-...